DoseRadarScan a label
Research library/Peppermint Oil
General Health · Ingredient guide

Peppermint Oil

Enteric-coated peppermint oil is studied for irritable-bowel-syndrome symptoms.

Compare
Evidence strengthModerate evidence
Based on consistency, quality and relevance of human research—not podcast mentions.
Common research protocol180–225 mg enteric-coated oil, 2–3 times daily in trials
Protocols mapped1 goal-specific protocol
Evidence reviewed throughSeptember 2026
Evidence verdict

Moderate evidence for the stated context. The evidence applies to enteric-coated oral products, not essential oil drops or aromatherapy.

Scientific evidence2 reviewed sourcesDetermines the evidence grade
Expert & media context0 reviewed sourcesDoes not change the grade alone
01

What it is & primary uses

Enteric-coated peppermint oil is studied for irritable-bowel-syndrome symptoms.

IBS symptom researchAbdominal painAntispasmodic effect
02

Main benefits

  • Can reduce global IBS symptoms and abdominal pain over the short term.
  • The evidence applies to enteric-coated oral products, not essential oil drops or aromatherapy.
03

Studied protocols

Research doses are grouped by outcome. They describe study designs—not a personal prescription.

IBS symptom research

180–225 mg enteric-coated oil, 2–3 times daily in trials

Moderate confidence
Study duration
Commonly 4–12 weeks; protocol and outcome vary
Interpretation
The evidence applies to enteric-coated oral products, not essential oil drops or aromatherapy.
04Food sources & equivalents
Food sources & equivalents

Can food provide a studied amount?

No direct food equivalent
Comparison target180–225 mg enteric-coated oil, 2–3 times daily in trials

Peppermint Oil in this supplemental form does not have a reliable one-to-one food equivalent.

Peppermint leaf tea is not dose-equivalent to enteric-coated oilFood amount varies

Dietary exposure; verify composition before comparing with a studied supplement dose

How this was estimated
Dose Radar compares the declared active ingredient with official composition data or the studied standardized extract—not with marketing names.
Important limitation
Natural content, preparation, bioavailability and formulation vary. This comparison does not prove equal physiological effect.

Food equivalents compare ingredient mass using published composition values. They do not prove equal absorption, formulation, physiological effect, safety or personal need.

Source: NCCIH peppermint oil evidence summary ↗
05How to take it for absorption & tolerance
Meal relationship

Empty stomach optional

Evidence-informed
Empty stomach optional; formulation and tolerance remain part of the comparison.

Fasting may change absorption or speed of onset, but tolerance and the studied formulation take priority.

Practical approach
Before meals according to the enteric-coated product. Keep the formulation and daily total consistent with the evidence context shown above.
Watch for
Acid-reducing medicines can affect enteric coating

Meal guidance reflects human pharmacokinetic, clinical, official-label or evidence-review sources where available. A food pairing can change absorption or tolerability, but does not make a supplement necessary, effective or safe for every person.

Source: NCCIH peppermint oil evidence summary ↗
06Supplement interaction check
Library interaction context156 ingredients · 0 mapped signals for this guide

An unlisted pair means no established pair-specific interaction was identified in this review—not proof that every dose, product or person is safe.

No pair-specific signal listedNo established interaction with another Dose Radar ingredient was identified in this review.

This is not proof that every dose, product or user context is safe. Medication and condition checks still apply.

07Research notes
Evidence verdict

Moderate evidence for the stated context. The evidence applies to enteric-coated oral products, not essential oil drops or aromatherapy.

The displayed amount comes from human research or an official evidence summary. It is not a personalized prescription, and formulation can change whether the comparison is valid.

TimingBefore meals according to the enteric-coated product
Time to expected effectStudy-specific; commonly several weeks
08Scientific references
Evidence sourceUsed to assess efficacy, protocols and confidence

Peer-reviewed human research and formal evidence reviews. Open each source to inspect the complete paper record.

Scientific evidence2026Official evidence summary↗ PubMed

NCCIH peppermint oil evidence summary

Dose context: 180–225 mg enteric-coated oil, 2–3 times daily in trials

Can reduce global IBS symptoms and abdominal pain over the short term. The evidence applies to enteric-coated oral products, not essential oil drops or aromatherapy.

Scientific evidence2026Living index of peer-reviewed human reviews↗ PubMed

Peppermint Oil: live PubMed review search

Dose context: Ingredient-specific human literature; dose and formulation vary

This live index supports source verification. A new paper does not change the Dose Radar grade until its design, population and formulation are reviewed.

09Expert & media references
Context sourceUsed to understand what professionals discuss

Podcast and practitioner statements are clearly separated from research. They may explain practice or emerging ideas, but do not prove efficacy.

0 reviewed context sourcesNo verified expert or media reference mapped yet.

Dose Radar will leave this lane empty rather than invent or infer a professional opinion.